Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carl E Allen
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
110 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- San Jorge Children'S Hospital
San Juan, Puerto Rico
- University Pediatric Hospital
San Juan, Puerto Rico
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- Banner Children'S at Desert
Mesa, Arizona, United States
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center
Downey, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Miller Children'S and Women'S Hospital Long Beach
Long Beach, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Mattel Children'S Hospital Ucla
Los Angeles, California, United States
- Valley Children'S Hospital
Madera, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Ucsf Benioff Children'S Hospital Oakland
Oakland, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke'S Medical Center
Denver, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida Health Science Center - Gainesville
Gainesville, Florida, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
- Nicklaus Children'S Hospital
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Arnold Palmer Hospital for Children
Orlando, Florida, United States
- Nemours Children'S Hospital
Orlando, Florida, United States
- Nemours Children'S Clinic - Pensacola
Pensacola, Florida, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Saint Joseph'S Hospital/children'S Hospital-Tampa
Tampa, Florida, United States
- Saint Mary'S Medical Center
West Palm Beach, Florida, United States
- Children'S Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Saint Jude Midwest Affiliate
Peoria, Illinois, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- Blank Children'S Hospital
Des Moines, Iowa, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Oct 2017
- Primary completion
- 30 Jun 2021
- Completion
- 31 Dec 2024
- Last update posted
- 5 Feb 2025
- Registered enrollment
- 21
- Registry id
- NCT03213691
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.